These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 35903906)

  • 21. Familial Mediterranean fever in childhood: a single-center experience.
    Barut K; Sahin S; Adrovic A; Sinoplu AB; Yucel G; Pamuk G; Aydın AK; Dasdemir S; Turanlı ET; Buyru N; Kasapcopur O
    Rheumatol Int; 2018 Jan; 38(1):67-74. PubMed ID: 28828621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can the Thiol/Disulfide Imbalance Be a Predictor of Colchicine Resistance in Familial Mediterranean Fever?
    Omma A; Sandikci SC; Kücüksahin O; Alisik M; Erel O
    J Korean Med Sci; 2017 Oct; 32(10):1588-1594. PubMed ID: 28875601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familial Mediterranean fever, review of the literature.
    Alghamdi M
    Clin Rheumatol; 2017 Aug; 36(8):1707-1713. PubMed ID: 28624931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A survey of resistance to colchicine treatment for French patients with familial Mediterranean fever.
    Corsia A; Georgin-Lavialle S; Hentgen V; Hachulla E; Grateau G; Faye A; Quartier P; Rossi-Semerano L; Koné-Paut I
    Orphanet J Rare Dis; 2017 Mar; 12(1):54. PubMed ID: 28302131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful management of colchicine resistant familial Mediterranean fever patients with a standardized canakinumab treatment protocol: a case series and literature review.
    Eren Akarcan S; Dogantan S; Edeer Karaca N; Aksu G; Kutukculer N
    Rheumatol Int; 2020 Jan; 40(1):161-168. PubMed ID: 31273456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health.
    Samuels J; Aksentijevich I; Torosyan Y; Centola M; Deng Z; Sood R; Kastner DL
    Medicine (Baltimore); 1998 Jul; 77(4):268-97. PubMed ID: 9715731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Canakinumab for the treatment of familial Mediterranean fever.
    Ozdogan H; Ugurlu S
    Expert Rev Clin Immunol; 2017 May; 13(5):393-404. PubMed ID: 28362189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Familial Mediterranean fever – an important disease in a globalised world].
    Wekell P; Karlsson A; Fasth A; Berg S
    Lakartidningen; 2016 Aug; 113():. PubMed ID: 27551868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Familial Mediterranean Fever (FMF): from diagnosis to treatment].
    Medlej-Hashim M; Loiselet J; Lefranc G; Mégarbané A
    Sante; 2004; 14(4):261-6. PubMed ID: 15745878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colchicine resistance and intolerance in familial mediterranean fever: Definition, causes, and alternative treatments.
    Ozen S; Kone-Paut I; Gül A
    Semin Arthritis Rheum; 2017 Aug; 47(1):115-120. PubMed ID: 28413100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Review: Familial Mediterranean Fever-An Overview of Pathogenesis, Symptoms, Ocular Manifestations, and Treatment.
    Petrushkin H; Stanford M; Fortune F; Jawad AS
    Ocul Immunol Inflamm; 2016 Aug; 24(4):422-30. PubMed ID: 25760918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial Mediterranean fever and its implications for fertility and pregnancy.
    Mijatovic V; Hompes PG; Wouters MG
    Eur J Obstet Gynecol Reprod Biol; 2003 Jun; 108(2):171-6. PubMed ID: 12781406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A retrospective analysis of 7 cases of familial mediterranean fever].
    Ogita C; Matsui K; Kisida D; Yazaki M; Nakamura A; Kaku S; Makino H; Tadokoro R; Azuma K; Tsuboi K; Tani M; Tamura M; Yoshikawa T; Morimoto M; Nishioka A; Sekiguchi M; Azuma N; Kitano M; Tsunoda S; Sawai H; Sano H
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(1):21-27. PubMed ID: 28539550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colchicine, Biologic Agents and More for the Treatment of Familial Mediterranean Fever. The Old, the New, and the Rare.
    Portincasa P
    Curr Med Chem; 2016; 23(1):60-86. PubMed ID: 26572612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colchicine resistance: Associated factors and its effect on health-related quality of life in patients with familial Mediterranean fever.
    Erdem Gürsoy D; Gezer HH; Öz N; Özer A; Acer Kasman S; Duruöz MT
    Int J Rheum Dis; 2022 Nov; 25(11):1239-1245. PubMed ID: 35903906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biological agents in familial Mediterranean fever focusing on colchicine resistance and amyloidosis.
    Sozeri B; Kasapcopur O
    Curr Med Chem; 2015; 22(16):1986-91. PubMed ID: 25760087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Approach to the patients with inadequate response to colchicine in familial Mediterranean fever.
    Gül A
    Best Pract Res Clin Rheumatol; 2016 Apr; 30(2):296-303. PubMed ID: 27886801
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.